Current therapeutic modalities for the management of chronic diabetic wounds of the foot
OA Oyebode, SW Jere… - Journal of diabetes …, 2023 - Wiley Online Library
Impaired wound healing is common in patients with diabetes mellitus (DM). Different
therapeutic modalities including wound debridement and dressing, transcutaneous …
therapeutic modalities including wound debridement and dressing, transcutaneous …
Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction
Background Diabetes mellitus (DM) represents a major cardiovascular risk factor for
increased risk of coronary artery disease and myocardial infarction (MI). DM is also …
increased risk of coronary artery disease and myocardial infarction (MI). DM is also …
Peripheral artery disease, lower limb revascularization, and amputation in diabetes patients with and without coronary artery disease: a cohort study from the Western …
KKW Olesen, C Gyldenkerne, T Thim… - BMJ Open Diabetes …, 2021 - drc.bmj.com
Introduction Patients with diabetes have increased risk of lower limb revascularization and
amputation due to higher risk of peripheral artery disease (PAD) and peripheral neuropathy …
amputation due to higher risk of peripheral artery disease (PAD) and peripheral neuropathy …
Ankle brachial index as a surrogate to vascular imaging in evaluation of peripheral artery disease in patients with type 2 diabetes
E Ugwu, A Anyanwu, M Olamoyegun - BMC Cardiovascular Disorders, 2021 - Springer
Background Peripheral artery disease (PAD) is common in persons with type 2 diabetes
(T2DM) and contributes significantly to cardiovascular morbidity and mortality. Controversy …
(T2DM) and contributes significantly to cardiovascular morbidity and mortality. Controversy …
Diabetes mellitus and its impact on patient-profile and in-hospital outcomes in peripheral artery disease
K Keller, VH Schmitt, M Vosseler… - Journal of clinical …, 2021 - mdpi.com
Background: In patients with peripheral artery disease (PAD), the impact of diabetes mellitus
(DM) on patient-profile and adverse in-hospital events is not well investigated. Methods: The …
(DM) on patient-profile and adverse in-hospital events is not well investigated. Methods: The …
Dyslipidaemia pattern and prevalence among type 2 diabetes mellitus patients on lipid-lowering therapy at a tertiary hospital in central South Africa
L Pitso, TRP Mofokeng, R Nel - BMC Endocrine Disorders, 2021 - Springer
Background Atherosclerotic cardiovascular disease (ASCVD) is a major cause of death
worldwide. A large number of deaths due to ASCVD occurs among people with diabetes …
worldwide. A large number of deaths due to ASCVD occurs among people with diabetes …
The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 …
X He, J Su, X Ma, W Lu, W Zhu, Y Wang, Y Bao… - Cardiovascular …, 2020 - Springer
Background Clinical and basic investigations have indicated a significant association
between circulating growth differentiation factor 15 (GDF15) and cardiovascular disease; …
between circulating growth differentiation factor 15 (GDF15) and cardiovascular disease; …
Atherosclerotic Cardiovascular Disease in Type 2 Diabetes: A Retrospective, Observational Study of Economic and Clinical Burden in Sweden
K Steen Carlsson, M Faurby, K Nilsson, ML Wolden - Diabetes Therapy, 2023 - Springer
Introduction Individuals with type 2 diabetes (T2D) are at high risk of experiencing
atherosclerotic cardiovascular disease (ASCVD), which is associated with morbidity …
atherosclerotic cardiovascular disease (ASCVD), which is associated with morbidity …
[HTML][HTML] Autologous bone-marrow vs. peripheral blood mononuclear cells therapy for peripheral artery disease in diabetic patients
E Yunir, F Kurniawan, E Rezaprasga… - … Journal of Stem Cells, 2021 - ncbi.nlm.nih.gov
Diabetes mellitus (DM) remains one of the most important risk factors for peripheral artery
disease (PAD), with approximately 20% of DM patients older than 40 years old are affected …
disease (PAD), with approximately 20% of DM patients older than 40 years old are affected …
[HTML][HTML] Risk stratification in people with diabetes for fasting during Ramadan: consensus from Arabic Association for the Study of Diabetes and Metabolism
I Shaltout, AM Abdelwahab, A El Meligi… - Current Diabetes …, 2024 - ncbi.nlm.nih.gov
Background Current international guidelines recommend a pre-Ramadan risk assessment
for people with diabetes (PwDM) who plan on fasting during the Holy month. However, a …
for people with diabetes (PwDM) who plan on fasting during the Holy month. However, a …